Patent · US Expired

Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect

US5372808A · kind A · utility

118Cited by
2References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 15, 1992
Grant dateDec 13, 1994
Priority date
Expiry dateApr 15, 2012

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for the treatment of cell proliferation disorders, viral infections, and other conditions without causing significant side effects normally associated with interferon therapy, involving administering to a patient in need thereof a therapeutically effective amount of consensus human leukocyte interferon are disclosed. Also disclosed are pharmaceutical compositions of consensus human leukocyte interferon.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.